Nirvana Life Science

Vancouver, Canada Founded: 2021 • Age: 5 yrs
Developer of therapeutics for the treatment of opioid addiction

About Nirvana Life Science

Nirvana Life Science is a company based in Vancouver (Canada) founded in 2021.. Nirvana Life Science has completed 1 acquisition, including MedSmart Staffing. Nirvana Life Science offers products and services including Psilocybin Formulations and Addiction Treatment Therapies. Nirvana Life Science operates in a competitive market with competitors including Entheon Biomedical, Clairvoyant Therapeutics and Alvarius, among others.

  • Headquarter Vancouver, Canada
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Nirvana Life Sciences Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $150 K (USD), Post-IPO

    Jun 15, 2022

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Nirvana Life Science

Nirvana Life Science is a publicly listed company on the CSE with ticker symbol NIRV in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: CSE · Ticker: NIRV . Sector: Health technology · Canada

Products & Services of Nirvana Life Science

Nirvana Life Science offers a comprehensive portfolio of products and services, including Psilocybin Formulations and Addiction Treatment Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Medicines to break opioid addiction and provide non-addictive pain relief.

Formulations targeting anxiety, depression, and addiction using psychedelics.

Funding Insights of Nirvana Life Science

  • Total Funding
  • Total Rounds 1
  • Last Round Post-IPO — $150,000
  • First Round

    (15 Jun 2022)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2022 Amount Post-IPO - Nirvana Life Science Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Nirvana Life Science

Nirvana Life Science has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ThreeD Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital firm focused on multiple sectors
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Nirvana Life Science

Nirvana Life Science has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MedSmart Staffing. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Staffing services for the medical imaging industry are provided.
2001
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Nirvana Life Science

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nirvana Life Science Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nirvana Life Science

Nirvana Life Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Entheon Biomedical, Clairvoyant Therapeutics and Alvarius, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Psychedelic medicines for addiction disorders are developed and patented.
domain founded_year HQ Location
Psychedelic therapy drugs for addiction treatment are manufactured.
domain founded_year HQ Location
Develops bio-pharmaceutical treatments for addiction via psychedelics and therapy.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nirvana Life Science

Frequently Asked Questions about Nirvana Life Science

When was Nirvana Life Science founded?

Nirvana Life Science was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is Nirvana Life Science located?

Nirvana Life Science is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.

Who is the current CEO of Nirvana Life Science?

Bruce Clark is the current CEO of Nirvana Life Science.

What does Nirvana Life Science do?

Developer of therapeutics for the treatment of opioid addiction. The company focuses on developing novel therapeutic products derived from psychedelics for pain management as well as treatment for ailments such as addiction, anxiety, and depression. The companys products inlcude a one-per-day gel cap that assists transition from opioids to non-addictive pain relief therapies.

Who are the top competitors of Nirvana Life Science?

Nirvana Life Science's top competitors include Clairvoyant Therapeutics, Entheon Biomedical and Alvarius.

What products or services does Nirvana Life Science offer?

Nirvana Life Science offers Psilocybin Formulations and Addiction Treatment Therapies.

Is Nirvana Life Science publicly traded?

Yes, Nirvana Life Science is publicly traded on CSE under the ticker symbol NIRV.

How many acquisitions has Nirvana Life Science made?

Nirvana Life Science has made 1 acquisition, including MedSmart Staffing.

Who are Nirvana Life Science's investors?

Nirvana Life Science has 1 investor. Key investors include ThreeD Capital.

What is Nirvana Life Science's ticker symbol?

The ticker symbol of Nirvana Life Science is NIRV on CSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available